Activity of ceftolozane/tazobactam against Gram-negative isolates from patients with lower respiratory tract infections – SMART United States 2018–2019

BACKGROUND: Ceftolozane/tazobactam (C/T) is approved in 70 countries, including the United States, for the treatment of patients with hospital-acquired and ventilator-associated bacterial pneumonia caused by susceptible Gram-negative pathogens. C/T is of particular importance as an agent for the tre...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:BMC Microbiol
Main Authors: Karlowsky, James A., Lob, Sibylle H., Young, Katherine, Motyl, Mary R., Sahm, Daniel F.
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2021
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7936229/
https://ncbi.nlm.nih.gov/pubmed/33676406
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12866-021-02135-z
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker